1) Hahn, A. et al. 2006. Ernährung. Physiologische Grundlagen, Prävention, Therapie. Stuttgart (Wiss. Verlag-Ges.)
2) Gröber, U. 2006. Osteoporose – Risikomanagement mit Vitalstoffen. Zs f Orthomol Med. 1:6–12.
3) Kenny, A. M. et al. 2004. Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporosis International 15, Nr. 4 (January): 290–294. doi:10.1007/s00198-003-1567-0.
4) Walker, A. F. et al. 2003. Mg citrate found more bioavailable than other Mg preparations in a randomized, double-blind study. Magnes Res. 16(3):183-91.
5) Arnett, T. 2003. Regulation of bone cell function by acid–base balance. Proceedings of the Nutrition Society 62, Nr.02:511–520. doi:10.1079/pns2003268.
6) Gröber, U. 2002. Orthomolekulare Medizin. Ein Leitfaden für Apotheker und Ärzte. Wissenschaftliche Verlagsgesellschaft mbH Stuttgart.
7) Bundesministerium für Gesundheit und Frauen. 2012. Österreichischer Ernährungsbericht.
8) Max Rubner Institut für Ernährung und Lebensmittel. 2012. Ergebnisse der Nationalen Verzehrsstudie II – Basisauswertung II.
9) Gennari, C. 2001. Calcium and vitamin D nutrition and bone disease of the elderly. Public Health Nutrition 4, Nr. 2b. doi:10.1079/phn2001140.
10) Bouillon, R. 2008. How effective is nutritional supplementation for the prevention of stress fractures in female military recruits? Nature Clinical Practice Endocrinology & Metabolism 4, Nr.9:486–487. doi:10.1038/ncpendmet0897.
11) Rodríguez-Martínez, M. et al. 2002. Role of Ca(2+) and vitamin D in the prevention and treatment of osteoporosis. Pharmacol Ther. 93(1):37–49.
12) Cranney, A. et al. 2007. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep). (158):1–235.
13) Robert Koch Institut; Statistisches Bundesamt. 2006. Gesundheit in Deutschland.
14) Rabijewski, M. et al. 2008. Pathogenesis, diagnosis and treatment of osteoporosis in men. Pol Merkur Lekarski. 24(139):76–80.
15) Shea, B. et al. 1998. Calcium supplementation on bone loss in postmenopausal women. The Cochrane Database of Systematic Reviews (February). doi:10.1002/14651858.cd004526.
16) Tezal, M. et al. 2000. The Relationship Between Bone Mineral Density and Periodontitis in Postmenopausal Women. Journal of Periodontology 71, Nr. 9: 1492–1498. doi:10.1902/jop.2000.71.9.1492.
17) Wactawski-Wende, J. 2001. Periodontal Diseases and Osteoporosis: Association and Mechanisms. Annals of Periodontology 6, Nr. 1: 197–208. doi:10.1902/annals.2001.6.1.197.
18) Wactawski-Wende, J. et al. 2005. The Association Between Osteoporosis and Alveolar Crestal Height in Postmenopausal Women. Journal of Periodontology 76, Nr. 11-s: 2116–2124. doi:10.1902/jop.2005.76.11-s.2116.
19) Krall, E. A. et al. 2001. Calcium and vitamin D supplements reduce tooth loss in the elderly. The American Journal of Medicine 111, Nr. 6: 452–456. doi:10.1016/s0002-9343(01)00899-3.
20) Nishida, M. et al. 2000. Calcium and the Risk For Periodontal Disease. Journal of Periodontology 71, Nr.7:1057–1066. doi:10.1902/jop.2000.71.7.1057.
21) Laver, D. R. et al. 2004. Luminal Ca2 – regulated Mg2 Inhibition of Skeletal RyRs Reconstituted as Isolated Channels or Coupled Clusters. The Journal of General Physiology 124, Nr.6:741–758. doi:10.1085/jgp.200409092.
22) Niestroj, I. 2000. Praxis der orthomolekularen Medizin. Physiologische Grundlagen, Therapie mit Mikro-Nährstoffen. 2. Auflage. Hippokrates Verlag GmbH. Stuttgart.
23) Kubalova, Z. et al. 2005. Abnormal intrastore calcium signaling in chronic heart failure. Proceedings of the National Academy of Sciences 102, Nr. 39: 14104–14109. doi:10.1073/pnas.0504298102.
24) Bo, S. et al. 2008. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Current Opinion in Lipidology 19, Nr. 1: 50–56. doi:10.1097/mol.0b013e3282f33ccc.
25) Wiederkehr, M. R. et al. 2004. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrology Dialysis Transplantation 19, Nr. 5: 1190–1197. doi:10.1093/ndt/gfh096.
26) Arnett, T. 2008. Extracellular pH regulates bone cell function. J Nutr. 138(2):415S–418S.
27) New, S. A. et al. 2004 Lower estimates of net endogenous non-carbonic acid production are positively associated with indexes of bone health in premenopausal and perimenopausal women. AmJ Clin Nutr. 79:131-8.
28) Kenny, J. E., Goldfarb, D.S. 2010. Update on the pathophysiology and management of uric acid renal stones. Curr Rheumatol Rep. 12(2):125-9.
29) Farwell, W. R., Taylor, E. N. 2010. Serum anion gap, bicarbonate and biomarkers of inflammation in healthy individuals in a national survey. CMAJ. 182(2):137-41.
30) Cseuz, R. M. et al. 2008. Basische Mineralstoffsupplementierung vermindert Schmerz bei Patienten mit Rheumatoider Arthritis: eine Pilot Studie. The Open Nutrition Journal. 100-105.
31) Farwell, W. R., Taylor, E. N. 2008. Serum bicarbonate, anion gap and insulin resistance in the National Health and Nutrition Examination Survey. Diabet Med. 25(7):798–804.
32) Taylor, E. N. et al. 2007. Serum anion gap and blood pressure in the national health and nutrition examination survey. Hypertension. 50(2):320-4.
33) Forman, J. P. et al. 2008. Association between the serum anion gap and blood pressure among patients at Harvard Vanguard Medical Associates. J Hum Hypertens. 22(2):122-5.
34) Hofmeyr, G. J. et al. 2007. Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary. BJOG. 114(8):933-43.
35) Ettinger, A. et al. 2007. Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation. J Nutr Biochem. 18(3):172–178.
36) Beinder E. 2007 Calcium-supplementation in pregnancy--is it a must? Ther Umsch. 64(5):243-7.
37) Ettinger, A. S. et al. 2009. Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial. Environ Health Perspect. 117(1):26–31. Epub 2008 Sep 2.
38) Whelan, A. M. et al. 2009. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 16(3):e407-29.
39) Quaranta, S. et al. 2007. Pilot study of efficacy and afety of a modified-release magnesium 250 mg tablet for the treatment of premenstrual syndrome. Clin Drug Investig. 27(1):51-8.
40) Facchinetti, F. et al. 1991. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 78(2):177-81.
41) Kaats, G. R. et al. 2011. A Comparative Effectiveness Study of Bone Density Changes in Women Over 40 Following Three Bone Health Plans Containing Variations of the Same Novel Plant-sourced Calcium. Int J Med Sci. 8(3):180–191.
42) Michalek, J. E. et al. 2011. Changes in total body bone mineral density following a common bone health plan with two versions of a unique bone health supplement: a comparative effectiveness research study. Nutrition Journal. 10: 32.
43) Adluri, R. S. et al. 2010. Comparative effects of a novel plant-based calcium supplement with two common calcium salts on proliferation and mineralization in human osteoblast cells. Mol Cell Biochem. 340(1–2):73-80.
44) Ishitani, K. et al. 1999. Calcium absorption from the ingestion of coral-derived calcium by humans. J Nutr Sci Vitaminol. 45(5):509-17.
45) Calbon®-N prevents loss of Bone Mineral Density. University of Hull. SON.DSH_14.057.EN.03
46) Salamone, L.M. 1996. The association between vitamin D receptor gene polymorphisms and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int. 6(1):63-8.
Referenzen Interaktionen
Stargrove, M. B. et al. Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, 1. Auflage. St. Louis, Missouri: Elsevier Health Sciences, 2008.
Gröber, U. Mikronährstoffe: Metabolic Tuning –Prävention –Therapie, 3. Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2011.
Gröber, U. Arzneimittel und Mikronährstoffe: Medikationsorientierte Supplementierung, 3. aktualisierte und erweiterte Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2014.
|